Medicalgorithmics Consistently Executes Its Strategy and Expands Service Sales
In the third quarter of 2024, Medicalgorithmics focused on increasing service sales and acquiring new clients, in line with its adopted strategy. During this period, service revenue amounted to PLN 5.2 million, with a 24% increase in the U.S. market compared to the second quarter, reaching PLN 1.2 million. This represents a recovery of 53% of the revenue from Q4 2023. Since the adoption of the new development strategy, the company has acquired 13 new clients. The Medicalgorithmics management expects to secure a major client in the U.S. by the end of this year, in accordance with its strategy, and to achieve positive cash flows in the second half of 2025.